Outcomes of Treat-and-Extend versus Pro Re Nata Anti-VEGF Injections for Myopic Macular Neovascularization in Patients in the United States

被引:0
作者
Swaminathan, Shreya [1 ]
Mahmoudzadeh, Raziyeh [2 ]
Wakabayashi, Taku [2 ]
Bowers, Mallory Elva [1 ]
Abishek, Robert [2 ]
Salabati, Mirataollah [2 ]
Hsu, Jason [2 ]
Dunn, James P. [2 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[2] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
[31]   Pro re nata anti-VEGF treatment results for neovascular age-related macular degeneration in routine clinical treatment: comparison of single with triple injections [J].
Wintergerst, M. W. M. ;
Larsen, P. P. ;
Heimes, B. ;
Pauleikhoff, D. ;
Holz, F. G. ;
Finger, R. P. .
OPHTHALMOLOGE, 2019, 116 (05) :441-446
[32]   Comparison of macular atrophy in eyes with neovascular age-related macular degeneration treated with VEGF inhibitors using a treat-and-extend or pro re nata regimen: 4-year results of the MANEX study [J].
Spooner, Kimberly ;
Fraser-Bell, Samantha ;
Cozzi, Mariano ;
Monteduro, Davide ;
Luo, Kehui ;
Hong, Thomas ;
Munk, Marion ;
Invernizzi, Alessandro ;
Staurenghi, Giovanni ;
Chang, Andrew .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 :63-63
[33]   Real-world outcomes for pro re nata and treat and extend regimens in exudative age-related macular degeneration [J].
Duncan, Holly ;
Stone, Lydia ;
Hogg, Jeffry ;
Gkorou, Olga ;
Blyth, Michelle ;
Brandes, Lesley ;
Devenport, Adele ;
Timms, Leanne ;
Talks, James .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
[34]   Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema-A Two-Year Matched Comparative Study [J].
Lai, Tso-Ting ;
Chen, Ta-Ching ;
Yang, Chang-Hao ;
Yang, Chung-May ;
Ho, Tzyy-Chang ;
Hsieh, Yi-Ting .
FRONTIERS IN MEDICINE, 2022, 8
[35]   Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema [J].
Gallardo, Mathias ;
Munk, Marion R. ;
Kurmann, Thomas ;
De Zanet, Sandro ;
Mosinska, Agata ;
Karagoz, Isil Kutluturk ;
Zinkernagel, Martin S. ;
Wolf, Sebastian ;
Sznitman, Raphael .
OPHTHALMOLOGY RETINA, 2021, 5 (07) :604-624
[36]   Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen [J].
Miere, Alexandra ;
Oubraham, Hassiba ;
Amoroso, Francesca ;
Butori, Pauline ;
Astroz, Polina ;
Semoun, Oudy ;
Bruyere, Elsa ;
Pedinielli, Alexandre ;
Addou-Regnard, Manar ;
Jung, Camille ;
Cohen, Salomon Y. ;
Souied, Eric H. .
JOURNAL OF OPHTHALMOLOGY, 2018, 2018
[37]   Outcomes of treat and extend and cessation with anti-VEGF in a large cohort of patients with pachychoroid related neovasculopathy [J].
Aizouki, Carolin ;
Mishra, Amit Vikram ;
Loh, Gracme K. ;
Ramachandran, Nishananth ;
Grewal, Parampal ;
Scamone, Mark E. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
[38]   Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study [J].
Michèle Augsburger ;
Gian-Marco Sarra ;
Pascal Imesch .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 :1889-1895
[39]   Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study [J].
Augsburger, Michele ;
Sarra, Gian-Marco ;
Imesch, Pascal .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (09) :1889-1895
[40]   Cost-Benefit Analysis of Intravitreal Anti-VEGF Medications for the Treatment of Neovascular Age-Related Macular Degeneration in a Treat-And-Extend Regimen [J].
Carey, Andrew ;
Russell, Stephen R. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)